165 related articles for article (PubMed ID: 37081411)
1. AC010883.5 promotes cell proliferation, invasion, migration, and epithelial-to-mesenchymal transition in cervical cancer by modulating the MAPK signaling pathway.
Gan Q; Huang X; Zhao W; Liu H; Xu Y; Zhang X; Cheng J; Chen R
BMC Cancer; 2023 Apr; 23(1):364. PubMed ID: 37081411
[TBL] [Abstract][Full Text] [Related]
2. LncRNA TDRG1 promotes the proliferation, migration, and invasion of cervical cancer cells by sponging miR-214-5p to target SOX4.
Guo M; Lin B; Li G; Lin J; Jiang X
J Recept Signal Transduct Res; 2020 Jun; 40(3):281-293. PubMed ID: 32106739
[TBL] [Abstract][Full Text] [Related]
3. LncRNA LINC01305 silencing inhibits cell epithelial-mesenchymal transition in cervical cancer by inhibiting TNXB-mediated PI3K/Akt signalling pathway.
Yan SP; Chu DX; Qiu HF; Xie Y; Wang CF; Zhang JY; Li WC; Guo RX
J Cell Mol Med; 2019 Apr; 23(4):2656-2666. PubMed ID: 30697971
[TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNA
Fan MJ; Zou YH; He PJ; Zhang S; Sun XM; Li CZ
Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31092700
[TBL] [Abstract][Full Text] [Related]
5. LncRNA-CTS promotes metastasis and epithelial-to-mesenchymal transition through regulating miR-505/ZEB2 axis in cervical cancer.
Feng S; Liu W; Bai X; Pan W; Jia Z; Zhang S; Zhu Y; Tan W
Cancer Lett; 2019 Nov; 465():105-117. PubMed ID: 31499118
[TBL] [Abstract][Full Text] [Related]
6. Golgi Phosphoprotein 3 Promotes Cervical Cancer Progression via Wnt/β-catenin Mediated Epithelial-Mesenchymal Transition.
Yang H; Ma X; Song B; Wang D; Chai Z
Ann Clin Lab Sci; 2023 Sep; 53(5):738-748. PubMed ID: 37945014
[TBL] [Abstract][Full Text] [Related]
7. LINC00997/MicroRNA 574-3p/CUL2 Promotes Cervical Cancer Development via Mitogen-Activated Protein Kinase Signaling.
Chu D; Liu T; Yao Y; Luan N
Mol Cell Biol; 2021 Jul; 41(8):e0005921. PubMed ID: 34031216
[TBL] [Abstract][Full Text] [Related]
8. The lncRNA LINC00675 regulates cell proliferation, migration, and invasion by affecting Wnt/β-catenin signaling in cervical cancer.
Ma S; Deng X; Yang Y; Zhang Q; Zhou T; Liu Z
Biomed Pharmacother; 2018 Dec; 108():1686-1693. PubMed ID: 30372871
[TBL] [Abstract][Full Text] [Related]
9. Mechanism underlying long non‑coding RNA ILF3‑AS1‑mediated inhibition of cervical cancer cell proliferation, invasion and migration, and promotion of apoptosis.
Zhu L; Chen R; Jiang C; Xie Q; Zhao W; Gao X; Huang H
Mol Med Rep; 2021 Aug; 24(2):. PubMed ID: 34080029
[TBL] [Abstract][Full Text] [Related]
10. LncRNA SNHG5 promotes cervical cancer progression by regulating the miR-132/SOX4 pathway.
Zhang L; Wu X; Li Y; Teng X; Zou L; Yu B
Autoimmunity; 2021 Mar; 54(2):88-96. PubMed ID: 33622094
[TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA BLACAT1 promotes cell proliferation, migration and invasion in cervical cancer through activation of Wnt/β-catenin signaling pathway.
Wang CH; Li YH; Tian HL; Bao XX; Wang ZM
Eur Rev Med Pharmacol Sci; 2018 May; 22(10):3002-3009. PubMed ID: 29863244
[TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA metastasis-associated lung adenocarcinoma transcript 1/microRNA-202-3p/periostin axis modulates invasion and epithelial-mesenchymal transition in human cervical cancer.
Han X; Wang Q; Wang Y; Hu B; Dong X; Zhang H; Wang W
J Cell Physiol; 2019 Aug; 234(8):14170-14180. PubMed ID: 30633360
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-497 accelerates apoptosis while inhibiting proliferation, migration, and invasion through negative regulation of the MAPK/ERK signaling pathway via RAF-1.
Tao L; Zhang CY; Guo L; Li X; Han NN; Zhou Q; Liu ZL
J Cell Physiol; 2018 Oct; 233(10):6578-6588. PubMed ID: 29150931
[TBL] [Abstract][Full Text] [Related]
14. Transcription factor ZNF488 accelerates cervical cancer progression through regulating the MEK/ERK signaling pathway.
Weng K; Li L; Zhou H
Histol Histopathol; 2023 Dec; 38(12):1381-1390. PubMed ID: 36537752
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of the long non-coding RNA UNC5B-AS1/miR-4455/RSPO4 axis reduces cervical cancer growth in vitro and in vivo.
Fu J; Zhang Y; Wang M; Hu J; Fang Y
J Gene Med; 2021 Dec; 23(12):e3382. PubMed ID: 34350661
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of long noncoding RNA SLC26A4-AS1 inhibits the epithelial-mesenchymal transition via the MAPK pathway in papillary thyroid carcinoma.
Wang DP; Tang XZ; Liang QK; Zeng XJ; Yang JB; Xu J
J Cell Physiol; 2020 Mar; 235(3):2403-2413. PubMed ID: 31556116
[TBL] [Abstract][Full Text] [Related]
17. Long noncoding RNA ROR1‑AS1 overexpression predicts poor prognosis and promotes metastasis by activating Wnt/β-catenin/EMT signaling cascade in cervical cancer.
Zhang L; Yao HR; Liu SK; Song LL
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):2928-2937. PubMed ID: 32271410
[TBL] [Abstract][Full Text] [Related]
18. TIM-1 promotes proliferation and metastasis, and inhibits apoptosis, in cervical cancer through the PI3K/AKT/p53 pathway.
Chen L; Qing J; Xiao Y; Huang X; Chi Y; Chen Z
BMC Cancer; 2022 Apr; 22(1):370. PubMed ID: 35392845
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of long non-coding RNA RP11-363E7.4 inhibits proliferation and invasion in gastric cancer.
Chen C; Wang X; Liu T; Tang X; Liu Y; Liu T; Zhu J
Cell Biochem Funct; 2020 Oct; 38(7):921-931. PubMed ID: 32141108
[TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA cancer susceptibility candidate 2 inhibits the cell proliferation, invasion and angiogenesis of cervical cancer through the MAPK pathway.
Wang XW; Zhang W
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3261-3269. PubMed ID: 31081078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
